Lenvatinib, (Lenvaxen) works for treating recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer, advanced renal cell carcinoma (RCC), hepatocellular carcinoma (HCC). It’s a doctor prescription (Lenvima/ Lenvatinib) medicine.
Everest Pharma Ltd. of Bangladesh mfg Lenvaxen.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Lenvaxen capsule may be taken with or without food, but it is better to take it at a fixed time.
Suggestion:
Any advice on the use of the drug is for reference only. Please consult with doctor for medical advice.
Genuine medicine is important for treatment. So, always try to source genuine medicines from authentic sources and check the quality of medicines.
Side Effect:
The most common side effects of Lenvatinib are:
Dry mouth, hoarseness, nose bleeds, tiredness, weight loss, headache, muscle/joint pain, trouble sleeping, change in taste, diarrhea, constipation, upset stomach, nausea, vomiting. Tell your doctor or pharmacist right away if any of these side effects persist or worsen.
Remember that your doctor has prescribed this medication because your doctor has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.
Tell your doctor right away if you have any serious side effects, including: signs of new or worsening kidney problems (such as change in the amount of urine, frothy urine), signs of heart failure (such as shortness of breath, swelling ankles/feet, unusual tiredness, unusual/sudden weight gain), signs of an underactive thyroid (such as weight gain, cold intolerance, slow heartbeat), muscle spasms, redness/pain/swelling/blisters on the palms of your hands or soles of your feet, easy bleeding/bruising, slow wound healing.
This is not a complete list of possible side effects. Contact your doctor or pharmacist if you have any other side effects not listed above.
Reviews
There are no reviews yet.